2014 | 2015 | χ2 | p value | |
---|---|---|---|---|
Control | ||||
Males | 58.8% (30/51) | 23.8% (19/80) | 6.29 | 0.01 |
Females | 38.1% (24/63) | 21.7% (15/69) | 1.78 | 0.18 |
2cy | 64.3% (18/28) | 51.4% (19/37) | 0.11 | 0.74 |
2cy+ | 41.9% (36/86) | 13.4% (15/112) | 10.90 | <0.001 |
Total | 47.4% (54/114) | 22.8% (34/149) | 7.87 | 0.005 |
Tagged | ||||
Males | 47.1% (8/17) | 18.5% (5/27) | 1.31 | 0.25 |
Females | 13.0% (3/23) | 9.1% (2/22) | 1.4e−30 | 1 |
2cy | 37.5% (6/16) | 21.4% (3/14) | 0.11 | 0.75 |
2cy+ | 20.8% (5/24) | 11.4% (4/35) | 0.23 | 0.63 |
Total | 27.5% (11/40) | 14.3% (7/49) | 0.99 | 0.32 |
Control | Tagged | χ2 | p value | |
---|---|---|---|---|
2014–2015 | ||||
Males | 37.4% (49/131) | 29.5% (13/44) | 0.24 | 0.63 |
Females | 29.5% (39/132) | 11.1% (5/45) | 3.22 | 0.07 |
2cy | 56.9% (37/65) | 30.0% (9/30) | 1.68 | 0.20 |
2cy+ | 25.8% (51/198) | 15.3% (9/59) | 1.39 | 0.24 |
Total | 33.5% (88/263) | 20.2% (18/89) | 2.69 | 0.10 |